Haploidentical, Unmanipulated Granulocyte Colony-Stimulating Factor (G-CSF)-Primed Peripheral Blood Stem Cell Transplants for Acute Myeloid Leukemia (AML) in Remission: A Single Center Experience.

CONCLUSIONS Our results showed that unmanipulated haploidentical transplantation with G-CSF primed PBSC alone as a graft source could be an acceptable alternative post-remission treatment for high-risk or intermediate-risk AML patients in CR1 lacking a matched donor.
PMID: 31221952 [PubMed - in process]

Source: Annals of Transplantation - June 20, 2019 Category: Transplant Surgery Authors: Luo L, Fang S, Zhao S, Li F, Zhou Y, Guan L, Yang N, Gu Z, Lin T, Wang F, Zhu C, Huang W, Liu D, Gao C Tags: Ann Transplant Source Type: research